Abstract
Infections caused by extended-spectrum β-lactamase (ESBL)-producing pathogens, particularly Klebsiella pneumoniae, are increasing. The epidemiology of ESBL-producing K. pneumoniae, the mechanisms of resistance, and treatment strategies for infections caused by these organisms are reviewed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Itokazu G, Quinn J, Bell-Dixon C, Kahan F, Weinstein R . Antimicrobial resistance rates among aerobic Gram-negative bacilli recovered from patients in intensive care units: Evaluation of a national postmarketing surveillance program . Clin Infect Dis 1996;23:779–784.
Burwen DR, Banerjee SN, Gaynes RP . Ceftazidime resistance among selected nosocomial Gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System. J Infect Dis 1994;170:1622–1625.
Karas JA, Pillay DG, Muckart D, Sturm AW . Treatment failure due to extended spectrum β-lactamase. J Antimicrob Chemother 1996;37:203–204.
Podschun R, Ullmann U . Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 1998;11:589–603.
Morgan ME, Hart CA, Cooke RW . Klebsiella infection in a neonatal intensive care unit: role of bacteriological surveillance. J Hosp Infect 1984;5:377–385.
Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S . Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983;11:315–317.
Quinn JP, Miyashiro D, Sahm D, Flamm R, Bush K . Novel plasmid-mediated β-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 1989;33:1451–1456.
Quale JM, Landman D, Bradford PA, et al. Molecular epidemiology of a citywide outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae infection. Clin Infect Dis 2002;35:834–841.
Athamna A, Ofek I, Keisari Y, et al. Lectinophagocytosis of encapsulated Klebsiella pneumoniae mediated by surface lectins of guinea pig alveolar macrophages and human monocyte-derived macrophages. Infect Immun 1991;59:1673–1682.
Griffiths E, Chart H, Stevenson P . High affinity iron uptake systems and bacterial virulence. In: Roth JA, editor. Virulence Mechanics of Bacterial Pathogens. Washington, DC: American Society for Microbiology; 1988.p. 121–137.
Nathisuwan S, Burgess DS, Lewis JS . Extended-spectrum β-lactamases: epidemiology, detection, and treatment. Pharmacotherapy 2001;21:920–928.
Jacoby GA, Sutton L . Properties of plasmids responsible for production of extended-spectrum β-lactamases. Antimicrob Agents Chemother 1991;35:164–169.
Sirot D, De-Champs C, Chanal C, et al. Translocation of antibiotic resistance determinants including an extended-spectrum β-lactamase between conjugative plasmids of Klebsiella pneumoniae and Escherichia coli. Antimicrob Agents Chemother 1991;35:1576–1581.
Venezia RA, Scarano FJ, Preston KE, et al. Molecular epidemiology of an SHV-5 extended-spectrum β-lactamase in enterobacteriaceae isolated from infants in a neonatal intensive care unit. Clin Infect Dis 1995;21:915–923.
National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A5. ed. Wayne, PA: NCCLS, 2000.
National Committee for Clinical Laboratory Standards. Approved standard M-100-S10: performance standards for antimicrobial susceptibility testing. ed. Wayne, PA: NCCLS, 2000.
Sirot D . Extended-spectrum plasmid-mediated β-lactamases. J Antimicrob Chemother 1995;36 (Suppl A): 19–34.
Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ . Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993;119:353–358.
Naumovski L, Quinn JP, Miyashiro D, et al. Outbreak of ceftazidime resistance due to a novel extended-spectrum β-lactamase in isolates from cancer patients. Antimicrob Agents Chemother 1992;36:1991–1996.
Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO . Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001;32:1162–1171.
Jacoby GA . Extended-spectrum β-lactamases and other enzymes providing resistance to oxyimino-β-lactams. Infect Dis Clin North Am 1997;11:875–887.
Jacoby GA . Editorial response: epidemiology of extended-spectrum β-lactamases. Clin Infect Dis 1998;27:81–83.
Gaillot O, Maruejouls C, Abachin E, et al. Nosocomial outbreak of Klebsiella pneumoniae producing SHV-5 extended-spectrum β-lactamase, originating from a contaminated ultrasonography coupling gel. J Clin Microbiol 1998;36:1357–1360.
French GL, Shannon KP, Simmons N . Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and β-lactam-β-lactamase inhibitor combinations by hyperproduction of SHV-5 β-lactamase. J Clin Microbiol 1996;34:358–363.
Casewell MW, Phillips I . Aspects of the plasmid-mediated antibiotic resistance and epidemiology of Klebsiella species. Am J Med 1981;70:459–462.
Gupta A, San Gabriel P, Haas J, et al. Extended spectrum ß-lactamase (ESBL) producing Klebsiella pneumoniae outbreak in a neonatal intensive care unit (NICU). Abstract 241. In: 12th Annual Scientific Meeting of Society for Healthcare Epidemiology of America (SHEA), Salt Lake City, UT, April, 2002. SHEA, 2002 (published).
Hart CA . Klebsiellae and neonates. J Hosp Infect 1993;23:83–86.
Stoll BJ, Gordon T, Korones SB, et al. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996;129:63–71.
Sohn AH, Garrett DO, Sinkowitz-Cochran RL, et al. Prevalence of nosocomial infections in neonatal intensive care unit patients: results from the first national point-prevalence survey. J Pediatr 2001;139:821–827.
Gaynes RP, Edwards JR, Jarvis WR, et al. Nosocomial infections among neonates in high-risk nurseries in the United States. National Nosocomial Infections Surveillance System. Pediatrics 1996;98:357–361.
Rice LB, Willey SH, Papanicolaou GA, et al. Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother 1990;34:2193–2199.
Paterson DL, Ko WC, Von-Gottberg A, et al. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol 2001;39:2206–2212.
Emery CL, Weymouth LA . Detection and clinical significance of extended-spectrum β-lactamases in a tertiary-care medical center. J Clin Microbiol 1997;35:2061–2067.
Jacoby GA, Carreras I . Activities of β-lactam antibiotics against Escherichia coli strains producing extended-spectrum β-lactamases. Antimicrob Agents Chemother 1990;34:858–862.
Payne DJ, Cramp R, Winstanley DJ, Knowles DJ . Comparative activities of clavulanic acid, sulbactam, and tazobactam against clinically important β-lactamases. Antimicrob Agents Chemother 1994;38:767–772.
Sanders WE, Sanders CC . Piperacillin/tazobactam: a critical review of the evolving clinical literature. Clin Infect Dis 1996;22:107–123.
Pillay T, Pillay DG, Adhikari M, Sturm AW . Piperacillin/tazobactam in the treatment of Klebsiella pneumoniae infections in neonates. Am J Perinatol 1998;15:47–51.
Mentec H, Vallois JM, Bure A, et al. Piperacillin, tazobactam, and gentamicin alone or combined in an endocarditis model of infection by a TEM-3-producing strain of Klebsiella pneumoniae or its susceptible variant. Antimicrob Agents Chemother 1992;36:1883–1889.
Leleu G, Kitzis MD, Vallois JM, Gutmann L, Decazes JM . Different ratios of the piperacillin–tazobactam combination for treatment of experimental meningitis due to Klebsiella pneumoniae producing the TEM-3 extended-spectrum β-lactamase. Antimicrob Agents Chemother 1994;38:195–199.
Piroth L, Aube H, Doise JM, Vincent-Martin M . Spread of extended-spectrum β-lactamase-producing Klebsiella pneumoniae: are β-lactamase inhibitors of therapeutic value? Clin Infect Dis 1998;27:76–80.
Schiappa DA, Hayden MK, Matushek MG, et al. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case–control and molecular epidemiologic investigation. J Infect Dis 1996;174:529–536.
Szabo D, Mathe A, Lengyel J, et al. In vitro and in vivo activities of ciprofloxacin and levofloxacin against an SHV-5 extended-spectrum β-lactamase-producing Klebsiella pneumoniae strain. Curr Med Chem 2002;9:437–442.
Paterson DL, Mulazimoglu L, Casellas JM, et al. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum β-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis 2000;30:473–478.
Takizawa T, Hashimoto K, Minami T, Yamashita S, Owen K . The comparative arthropathy of fluoroquinolones in dogs. Hum Exp Toxicol 1999;18:392–399.
Boyce JM, Pittet D, HICPAC, et al. Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR Recomm Rep 2002;51:1–45, quiz CE1-4.
Coovadia YM, Johnson AP, Bhana RH, et al. Multiresistant Klebsiella pneumoniae in a neonatal nursery: the importance of maintenance of infection control policies and procedures in the prevention of outbreaks. J Hosp Infect 1992;22:197–205.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gupta, A., Ampofo, K., Rubenstein, D. et al. Extended Spectrum β Lactamase-producing Klebsiella pneumoniae Infections: a Review of the Literature. J Perinatol 23, 439–443 (2003). https://doi.org/10.1038/sj.jp.7210973
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jp.7210973
This article is cited by
-
Antibiotic resistance modifying ability of phytoextracts in anthrax biological agent Bacillus anthracis and emerging superbugs: a review of synergistic mechanisms
Annals of Clinical Microbiology and Antimicrobials (2021)
-
Comparisons of microbiological characteristics and antibiotic resistance of Klebsiella pneumoniae isolates from urban rodents, shrews, and healthy people
BMC Microbiology (2020)
-
Genetic diversity and multiple antibiotic resistance index study of bacterial pathogen, Klebsiella pneumoniae strains isolated from diseased Indian major carps
Folia Microbiologica (2019)
-
Inhibition of Klebsiella Pneumoniae DnaB Helicase by the Flavonol Galangin
The Protein Journal (2011)
-
Identification and Characterization of a Putative Dihydroorotase, KPN01074, from Klebsiella pneumoniae
The Protein Journal (2010)